Beech Hill Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Sell
3,918
-33
-0.8% -$15.8K 0.87% 46
2026
Q1
$1.94M Buy
3,951
+486
+14% +$264K 0.97% 46
2025
Q4
$2.01M Sell
3,465
-628
-15% -$355K 0.96% 45
2025
Q3
$1.99M Sell
4,093
-798
-16% -$371K 0.93% 46
2025
Q2
$1.98M Buy
4,891
+401
+9% +$168K 0.89% 49
2025
Q1
$2.23M Buy
+4,490
New +$2.43M 0.89% 48

Other funds holding TMO

Beech Hill Advisors's TMO Position: Q2 2026 in Review

Beech Hill Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.84% in Q2 2026, selling an estimated $15.8K and leaving 3,918 shares worth $1.96M. The position accounts for 0.87% of the portfolio, ranked #46.

Beech Hill Advisors first reported a position in TMO in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.23M in Q1 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Beech Hill Advisors held 3,918 shares of Thermo Fisher Scientific worth $1.96M as of Q2 2026.
  • Beech Hill Advisors sold 33 Thermo Fisher Scientific shares in Q2 2026, an estimated $15.8K.
  • Thermo Fisher Scientific made up 0.87% of Beech Hill Advisors's portfolio in Q2 2026, its #46 holding.
  • Beech Hill Advisors first reported a position in Thermo Fisher Scientific in Q1 2025 and has held it in 6 quarters since.
  • Beech Hill Advisors's Thermo Fisher Scientific position peaked at $2.23M in Q1 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Beech Hill Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.